Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

23,511 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Treatment Rechallenge With Immune Checkpoint Inhibitors in Advanced Urothelial Carcinoma.
Makrakis D, Bakaloudi DR, Talukder R, Lin GI, Diamantopoulos LN, Jindal T, Vather-Wu N, Zakharia Y, Tripathi N, Agarwal N, Dawsey S, Gupta S, Lu E, Drakaki A, Liu S, Zakopoulou R, Bamias A, Fulgenzi CM, Cortellini A, Pinato D, Barata P, Grivas P, Khaki AR, Koshkin VS. Makrakis D, et al. Among authors: gupta s. Clin Genitourin Cancer. 2023 Apr;21(2):286-294. doi: 10.1016/j.clgc.2022.11.003. Epub 2022 Nov 13. Clin Genitourin Cancer. 2023. PMID: 36481176 Free article.
Activin receptor inhibitors--dalantercept.
Gupta S, Gill D, Pal SK, Agarwal N. Gupta S, et al. Curr Oncol Rep. 2015 Apr;17(4):14. doi: 10.1007/s11912-015-0441-5. Curr Oncol Rep. 2015. PMID: 25708802 Review.
Clinical Outcomes After Neoadjuvant Chemotherapy and Radical Cystectomy in the Presence of Urothelial Carcinoma of the Bladder With Squamous or Glandular Differentiation.
Zargar-Shoshtari K, Sverrisson EF, Sharma P, Gupta S, Poch MA, Pow-Sang JM, Spiess PE, Sexton WJ. Zargar-Shoshtari K, et al. Among authors: gupta s. Clin Genitourin Cancer. 2016 Feb;14(1):82-8. doi: 10.1016/j.clgc.2015.08.006. Epub 2015 Aug 29. Clin Genitourin Cancer. 2016. PMID: 26411593
Immunotherapy Advances in Urothelial Carcinoma.
Jain RK, Snyders T, Nandagopal L, Garje R, Zakharia Y, Gupta S. Jain RK, et al. Among authors: gupta s. Curr Treat Options Oncol. 2018 Dec 15;19(12):79. doi: 10.1007/s11864-018-0598-x. Curr Treat Options Oncol. 2018. PMID: 30554335 Review.
Circulating tumor DNA alterations in patients with metastatic castration-resistant prostate cancer.
Sonpavde G, Agarwal N, Pond GR, Nagy RJ, Nussenzveig RH, Hahn AW, Sartor O, Gourdin TS, Nandagopal L, Ledet EM, Naik G, Armstrong AJ, Wang J, Bilen MA, Gupta S, Grivas P, Pal SK, Lanman RB, Talasaz A, Lilly MB. Sonpavde G, et al. Among authors: gupta s. Cancer. 2019 May 1;125(9):1459-1469. doi: 10.1002/cncr.31959. Epub 2019 Jan 8. Cancer. 2019. PMID: 30620391 Free article.
Correction to: Immunotherapy Advances in Urothelial Carcinoma.
Jain RK, Snyders T, Nandagopal L, Garje R, Zakharia Y, Gupta S. Jain RK, et al. Among authors: gupta s. Curr Treat Options Oncol. 2019 May 23;20(7):53. doi: 10.1007/s11864-019-0660-3. Curr Treat Options Oncol. 2019. PMID: 31119396
Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium.
Paller CJ, Antonarakis ES, Beer TM, Borno HT, Carlo MI, George DJ, Graff JN, Gupta S, Heath EI, Higano CS, McKay RR, Morgans AK, Patnaik A, Petrylak DP, Rettig MB, Ryan CJ, Taplin ME, Whang YE, Vinson J, Cheng HH, Giri VN; PCCTC Germline Genetics Working Group. Paller CJ, et al. Among authors: gupta s. Clin Genitourin Cancer. 2019 Aug;17(4):275-282.e1. doi: 10.1016/j.clgc.2019.04.013. Epub 2019 Apr 18. Clin Genitourin Cancer. 2019. PMID: 31171481 Free PMC article.
23,511 results
You have reached the last available page of results. Please see the User Guide for more information.